R&D
Company credited for technology, KyungDong Pharm
Research Outcome
Finished Drugs
Date | Product Name | |
---|---|---|
2018's | Jan | Antihistamine [ Beporizin tab.5mg ] |
2017's | Dec | Antihistamine [ Beporizin tab.10mg ] |
Oct | Antidiabetic [ Pictomin Tab. ] | |
Aug | Antiviral [ Byaflu Cap.75mg ] | |
Jul | Cardiovascular [ Huleg Tab. ] | |
Urology [ Solfecin Tab. 5mg, 10mg ] | ||
CNS [ Slipin tab.6mg ] | ||
Jun | Vitamin D3 [ Vidien inj. ] | |
ATP Energy Inj. [ Kyungdong ATP Inj. ] | ||
May | Alpha-Lipoic acid [ Antioxan Inj. ] | |
Vitamin B12 [ Vita B Dozen Inj. ] | ||
Vitamin B6 [ Vita B6 Injection ] | ||
2016's | Oct | Vitamin complex [ Kyungdong Multivitamin Inj. ] |
Aug | Antibacterial [ Cebuzone Injection 500mg ] | |
2015's | Sep | Urology [ The Forte-C Tab. 5mg, 20mg ] |
Jul | Gastrointestinal [ Setoride Tab. ] | |
Jun | Pain/Inflammation [ Seleca Tab. 200mg ] | |
Feb | Corticosteroid [ Dexasin Inj. ] | |
Jan | Antihistamine [ Cozoltec Tab. ] | |
2014's | Jun | Antihistamine agent [ Phenil Inj. ] |
Mar | Non-steroidal anti-inflammatory drugs [ Linac Inj. ] | |
2013's | Oct | Treatment of Hypertension [ Valdipine Tab. ] |
Jun | Treatment of Hyperlipidemia [ Atrovan Tab. 20mg ] | |
Mar | Treatment for Erectile dysfunction [ Forte-V Tab. 50mg ] | |
2012's | Sep | Treatment of Chronic Heptitis B [ Lamiffix Tab. ] |
Jun | Treatment for Erectile dysfunction [ Forte-V Tab. 100mg ] | |
2011's | Dec | Third-generation Cephalosporins [ Cefpivo Tab. ] |
Nov | Treatment of Hypertension [ Valtrep Plus F Tab. ] | |
Treatment of Hypertension [ Valtrep Plus Tab. ] | ||
Treatment of Hypertension [ Valtrep Tab. 80mg, 160mg ] | ||
Jun | Treatment of Hypertension [ Irbetan Plus F Tab. ] | |
Treatment of Hypertension [ Irbetan Plus Tab. ] | ||
Treatment of Hypertension [ Irbetan Tab. 150mg, 300mg ] | ||
Apr | Treatment of Hypertension [ Cansata Ples Tab. ] | |
Treatment of Hypertension [ Cansata Tab. 8mg, 16mg ] | ||
Mar | Treatment of Functional Dyspepsia [ Gaspren Tab. ] |